Ye Ting-Mei, Zhang Shi-Zhong, Xia Qiang
Lishui College, Lishui 323000, China.
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2006 May;22(2):136-40.
To investigate the role and mechanism of mitochondrial calcium uniporter (MCU) in myocardial hypoxia/reoxygenation injury.
Isolated rat hearts were perfused with Langendorff apparatus. The hypoxia/reoxygenation injury was achieved by ligation of left anterior coronary artery for 30 min followed by release of ligation for 120 min. The left ventricular developed pressure (LVDP), the maximum rise/fall rate of left ventricular pressure (+/- dP/dt(max)), and the left ventricular end-diastolic pressure (LVEDP) were recorded. Activities of lactate dehydrogenase (LDH) in coronary effluent and reactive oxygen species (ROS) of myocardial mitochondria were spectrophotometrically assayed. Infarct size was determined by TTC staining method.
Compared with the hypoxia/reoxygenation (H/R) group, ruthenium red (RR, 5 micromol/L), given at the on set of reoxygenation, significantly improved the contractile function of left ventricle, decreased the myocardial infarct size, alleviated the production of ROS in myocardial mitochondria and LDH release in coronary effluent. Spermine (20 micromol/L), given at the onset of reoxygenation, enhanced the production of ROS in the mitochondria and LDH release in coronary effluent at 5, 20 and 30 min of reoxygenation, however, there were no significant differences of ventricular contractile parameters and infarct size between groups subjected to hypoxia/reoxygenation with or without spermine treatment. Co-treatment of ROS scavenger N-2-mercaptopropionyl glycine (1 mmol/L) with spermine abolished the effect of spermine.
Inhibition of mitochondrial calcium uniporter may refrain heart from hypoxia/reoxygenation injury via decreasing the production of ROS in heart mitochondria.
探讨线粒体钙单向转运体(MCU)在心肌缺氧/复氧损伤中的作用及机制。
采用Langendorff装置灌注离体大鼠心脏。通过结扎左冠状动脉30分钟后再松开结扎120分钟来实现缺氧/复氧损伤。记录左心室发展压(LVDP)、左心室压力最大上升/下降速率(+/- dP/dt(max))和左心室舒张末期压力(LVEDP)。用分光光度法测定冠状动脉流出液中乳酸脱氢酶(LDH)的活性和心肌线粒体活性氧(ROS)的水平。采用TTC染色法测定梗死面积。
与缺氧/复氧(H/R)组相比,在复氧开始时给予钌红(RR,5 μmol/L)可显著改善左心室收缩功能,减小心肌梗死面积,减轻心肌线粒体ROS的产生以及冠状动脉流出液中LDH的释放。在复氧开始时给予精胺(20 μmol/L),在复氧5、20和30分钟时可增强线粒体ROS的产生以及冠状动脉流出液中LDH的释放,然而,在接受或未接受精胺治疗的缺氧/复氧组之间,心室收缩参数和梗死面积无显著差异。ROS清除剂N-2-巯基丙酰甘氨酸(1 mmol/L)与精胺联合处理可消除精胺的作用。
抑制线粒体钙单向转运体可能通过减少心脏线粒体ROS的产生来避免心脏发生缺氧/复氧损伤。